Question Bank › Ground-level proof points accumulating

Ground-level proof points accumulating

Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea

Calls Tested
322
Answered YES
8
Hit Rate
2.5%
rare by design

Alkermes plc (ALKS) — this company's answers

NO on the Q3 2018 call 2018-10-23 C
The model's full reasoning — Q3 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from inside the business, each one identifiable on its own — AND does management explicitly treat these accumulating episodes as the LEADING EDGE of a broader improvement that is still early? We need to check both halves. First, are there at least three distinct, named or individually identifiable episodes from the recent period? The episodes must be ground-level, specific, recent, and described enough to distinguish. They can be particular customers, accounts, partners, sites, products, etc. Also, management must connect these episodes into a building pattern that is still early. Let's scan the transcript for such episodes. From Jim Robinson's section on VIVITROL: He mentions "we continue to see strong growth of VIVITROL in a number of states driven by a variety of policy initiatives both in the community and the criminal justice setting as well as improvements in access to VIVITROL. While the top five states represent approximately 45% of VIVITROL volume overall, growth is widespread across the country. Year-to-date, 27 states have demonstrated more than 25% growth year-over-year, and we are particularly encouraged by the growth of VIVITROL in states like Pennsylvania, California, Florida, Michigan and Kentucky." That's more aggregate, not specific episodes. He also mentions "we are expanding our capabilities to respond to the evolving market dynamics, including through the addition of key account managers and field-based reimbursement managers." That's a plan, not an episode. On ARISTADA: He says "The quarter was highlighted by the launch of our new initiation product ARISTADA INITIO." That's a product launch, but is it an episode? It's a launch, but it's a product launch, not a specific ground-level win like a particular account. He also says "we have seen an acceleration in the sequential growth of the two-month dose, which grew 26% and accounted for 15% of ARISTADA's volume in the third quarter." That's a metric. He mentions "the addition of both ARISTADA and ARISTADA INITIO to formularies at more than 30 hospitals during the quarter.

← Back to the full ALKS analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from inside the business, each one identifiable on its own — AND does management explicitly treat these accumulating episodes as the LEADING EDGE of a broader improvement that is still early? Answer YES when BOTH halves come through in management's own words, in whatever form fits the business: (1) AT LEAST THREE DISTINCT, NAMED OR INDIVIDUALLY IDENTIFIABLE EPISODES FROM THE RECENT PERIOD. Management recounts multiple separate ground-level events that actually happened recently — each described specifically enough that a listener could tell the episodes apart and could later check them. The episodes may take whatever form fits the industry: a particular customer, account, or partner that signed, reordered, expanded, or went live; a particular site, store, plant, line, rig, clinic, or facility that opened, hit a milestone, or reached a new performance level; a particular product, program, or offering that shipped its first units, won its first placements, or crossed a threshold; a particular region, channel, or contract that turned on or stepped up. What matters is the GRANULARITY and RECENCY: these are individually small, freshly occurred, operator-level facts — the kind of detail only people close to the business would narrate — not aggregate results, percentages, themes, or claims like "demand was strong across the board." (2) MANAGEMENT ITSELF CONNECTS THE EPISODES INTO A BUILDING PATTERN THAT IS STILL EARLY. Management explicitly draws the line from these individual episodes to a larger developing trajectory — conveying, in its own voice, that these wins are instances of the same underlying thing, that more of the same kind are already forming or arriving, and that the pattern's contribution to reported results is only beginning, so most of it lies ahead. The generalization must be management's own act, grounded in the recounted episodes — not a hope, a market-size claim, or an analyst's summary. Answer NO if the call's positive story is carried mainly by aggregates — overall growth rates, segment percentages, or general demand commentary — without several individually identifiable recent episodes. NO if fewer than three distinct episodes are described, or the episodes are really one event told from different angles. NO if the episodes are plans, pipeline items, letters of intent, or hoped-for events rather than things that already happened. NO if the episodes are the routine cadence this company always reports (its usual pace of customer additions, standard seasonal openings) and management does not present their accumulation as new or building. NO if management recounts the episodes but never itself connects them into a broader, still-early pattern with more arriving. NO if the episodes chiefly explain problems, or the call is mainly defense of weak results. NO if the pattern-framing appears only in an analyst's question or summary that management does not itself adopt. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CRGO Freightos Limited Q1 2024 2024-05-20 C+
MBLY Mobileye Global Inc. Q2 2023 2023-07-28 B+
TOST Toast, Inc. Q4 2022 2023-02-16 C+
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
AU AngloGold Ashanti's Q2 2018 2018-08-20 B
MITK Mitek Systems, Inc. Q4 2017 2017-11-07 C+
TGI Triumph Group, Inc. Q2 2017 2016-11-03 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

AU · Q2 2018 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple specific, recent operational episodes: Kibali’s underground ramp-up with automated ore handling system and vertical shaft integration; Iduapriem’s CIL tank conversion and grade/tonnage gains; Sunrise Dam’s Recovery Enhancement Project plus new mining strategies; Tropicana’s second 6-MW ball mill installation; Siguiri’s CIL circuit milestone; and 338 tracked Operational Excellence projects.
BXP · Q1 2022 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple distinct, named episodes from the recent period: the 73,000 sq ft recapture/release at 77 CityPoint with a 15% rent increase and 7.
CRGO · Q1 2024 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...

More from the question bank

Conversion calendar in handFresh order-of-magnitude reference changeBetting on a customer they cannot yet nameOutside actors already movingWinning more per swing than they used to — aPriced for a smaller companyAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.